High Dose Extended Interval Aminoglycoside Dosing/Monitoring Guidelines

Studies indicate that high dose extended interval dosing (HDEID) of aminoglycosides (AGs) results in at least comparable efficacy as conventional dosing, decreased or equal nephrotoxicity and comparable ototoxicity, and requires less serum level monitoring.